D. Fraser Gray

5.6k citations
12 papers · 4.8k · 3 hit papers · h-index 9

Impact in

  • Epidemiology top 0.5%
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment
  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Hepatitis C virus research
    • Liver physiology and pathology
    • Liver Disease and Transplantation

Papers in

D. Fraser Gray

12 papers receiving 4.5k citations

D. Fraser Gray's Hit Papers

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease 2004 · 1.9k citations
1.9k0+9+18Years since publication5001k1.5k

Peers

D. Fraser Gray
Comparison fields: 5 of 87
  • Epidemiology 4.1k
  • Hepatology 790
  • Applied Microbiology and Biotechnology 5
  • Infectious Diseases 39
  • Economics and Econometrics 57
Replace Richard Guan with:
Richard Guan Singapore
Young Myoung Moon South Korea
Nicolaos C. Tassopoulos United States
George E. Kitis Greece
Naoky C. S. Tsai United States
Anuchit Chutaputti Thailand
Benjamin Maasoumy Germany
Pui–Chee Wu Hong Kong
Alexandra L. Gibas United States
Sylvia Dražilová Slovakia
D. Fraser Gray relative to Richard Guan Singapore Richard Guan's profile →
Citations per field
00.5×1.7×
Richard Guan · 1×
Citations per year

Countries citing papers authored by D. Fraser Gray

Since Specialization
Citations

This map shows the geographic impact of D. Fraser Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Fraser Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Fraser Gray more than expected).

Fields of papers citing papers by D. Fraser Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Fraser Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Fraser Gray. The network helps show where D. Fraser Gray may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Fraser Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Fraser Gray Line = papers co-authored together D. Fraser Gray links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Hit paper breakdown →
20041925
2
A One-Year Trial of Lamivudine for Chronic Hepatitis B
Hit paper breakdown →
19981510
3
Histological outcome during long-term lamivudine therapy
Hit paper breakdown →
2003626
4
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
2003464
5 2008130
6 199839
7 199836
8 199922
9 199813
10 19987
11 20014
12 19983

About D. Fraser Gray

D. Fraser Gray is a scholar working on Epidemiology, Hepatology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 12 papers that have together received 4.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (1 paper). The work is most often cited by research in Epidemiology (4.1k citations), Hepatology (790 citations), Applied Microbiology and Biotechnology (5 citations), Infectious Diseases (39 citations) and Economics and Econometrics (57 citations). D. Fraser Gray has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Sally L. Stephenson, Joseph J.�Y. Sung, G C Farrell, Oliver N. Keene, Wan Cheng Chow, Jonathan S. Dixon, Cha‐Ze Lee, Yun‐Fan Liaw, Tawesak Tanwandee and Julie C. Dent. Their work appears in journals such as Journal of Hepatology, Gastroenterology, New England Journal of Medicine and European Journal of Gastroenterology & Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact